T-Kininogen is one of the acute phase proteins, and is a precursor of T-kinin and a cysteine protease inhibitor. Two homologous T-kininogens (TI-and Tll-kininogens) were isolated from microsomal fraction of inflamed rat liver, by chromatographies on columns of DEAESepharose CL-6B and DEAE-5PW and by affinity chromatography on a column of anti T-kininogen monoclonal antibody. The amino terminal amino acid sequences of the two microsomal pyridylethylated T-kininogens after pyroglutamyl aminopeptidase treatment were identical with those of TI-and Tll-kininogens from inflamed rat plasma. Microsomal T-kininogens moved faster on SDS-PAGE after treatment with endoglycosidase H. The amounts of microsomal TI-and Tll-kininogens in inflamed and non-inflamed rat liver were quantitated by immunoblotting of homogenates of liver microsomes using anti T-kininogen rabbit antiserum. The amounts of microsomal T-kininogens were increased in inflamed rat liver, but the ratio of the amounts of TI-kininogen to TII-kininogen was not different in the inflamed and non-inflamed rat liver. On the other hand, TII-kininogen was not significantly detected in non-inflamed rat plasma. These results indicate that the secretion of one of the T-kininogens, TII-kininogen, into plasma may be prevented by some unknown mechanism.
The hepatic synthesis of several plasma proteins, acute phase proteins, is stimulated after acute systemic injury or infection. The increase of the circulating concentrations of these proteins is shown to be mediated by cytokines from activated macrophages, which interact with the responsible gene elements (1, 2) . It has been demonstrated that T-kininogen, a precursor protein of T-kinin in rat plasma, is an acute phase protein with cysteine protease inhibitor activity (3) (4) (5) . T-Kininogen gene consists of two highly homologous genes for TI-and Tll-kininogens (6, 7) , whose expression are modulated by interleukin 6 (IL-6) (8) . The presence of IL-6 responsive elements in T-kininogen gene was recently demonstrated (9) . Although another kininogen gene, K-kininogen gene, exists in rat and other mammals, only T-kininogen is induced by inflammation (10, 11).
In the previous papers (12, 13) , we described the purification and characterization of T-kininogens in inflamed and non-inflamed rat plasma and demonstrated that of the two homologous T-kininogens, TI-and Tll-kininogens, TJl-kininogen was hardly detectable in non-inflamed rat plasma, whereas both of them greatly increased in plasma after inflammation. On the other hand, almost equal amounts of mRNA for TI-and Tll-kininogens were shown to be present in non-inflamed rat liver RNA, as in inflamed rat liver (14, 15) . Therefore, both T-kininogens seem to be 1 This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan. 1 To whom correspondence should be addressed. Abbreviations: APMSF, jo-amidinophenyl methanesulfonyl fluoride; BSA, bovine serum albumin; SDS-PAGE, polyacrylamide gel electrophoresis in the presence of sodium dodecyl snlfate; ELISA, eniyme-1 inked immunoeorbent assay.
equally synthesized in microsomeB but the secretion of TII-kininogen into plasma may be prevented in non-inflamed rat. This study was undertaken to prove that TI-and Tll-kininogens are equally present in microsomes of noninflamed rat liver. Both microsomal T-kininogens were first purified from microsomes of inflamed rat liver and characterized in comparison with plasma T-kininogens. Then, the amounts of TI-and Tll-kininogens in microsomes from inflamed and non-inflamed rat liver were quantitated. The results indicate that the ratio of TI-kininogen to TIIkininogen was not different in microsomes from inflamed and non-inflamed rat liver; therefore, the secretion of microsomal TII-kininogen may be prevented in non-inflamed rat.
MATERIALS AND METHODS
Sprague-Dawley rats were purchased from SLC, Shizuoka. T-Kininogens, TI-kininogen and TII-kininogen, were purified from plasma of non-inflamed or inflamed rats as reported previously (12, 13) . Lipopolysaccharide (phenol extract of Escherichia coli 0111 :B4) and BSA were products of Sigma Chemicals, St. Louis, MO, U.S.A. DEAESepharose CL-6B was a product of Pharmacia LKB Biotechnology Japan, Tokyo. DEAE-5PW was a product of Tosoh Industry, Tokyo. Monoclonal antibody against rat T-kininogen was kindly supplied by Prof. Sachiko Oh-ishi, Faculty of Pharmaceutical Sciences, Kitasato University, Tokyo. Polyclonal antibody against T-kininogen was prepared as described previously (12) . A monoclonal antibody column was prepared by coupling monoclonal antibody against T-kininogen with Affigel 10 (Bio-Rad Laboratories, Richmond, U.S.A.). Rat urinary kaUikrein (specific activity toward Pro-Phe-Arg-methylcoumaryl amide, 3.7 //mol per m 0.12 0 100 200 300 Fraction Number (10 ml/tube) Fig. 1 . DEAE-Sepharose CL-6B column chromatography of the supernatant of sodium deoxycholate-treated mlcrosomes from inflamed rat liver. Microsomes were prepared from inflamed rat liver as described under "MATERIALS AND METHODS" and the supernatant of sodium deoxycholate-treated suspension was applied to a column (4.6x20.5 cm) of DEAE-Sepharose CL-6B, which had been equilibrated with 20 mM Tris-HCl, pH 8.0, containing 3 mM benzamidine. Protein was eluted with a linear salt gradient formed from 2 liters each of the equilibration buffer and the buffer containing 0.3 M NaCl. Fractions of 10 ml were collected. T-Kininogen was assayed by ELJSA as described under "MATERIALS AND METH-ODS." Three fractions, I, II, and HI, were pooled as indicated by I II III Fig. 2 . Immunoblotting of microsomal T-klnlnogen fractions from DEAE-Sepharose C1-6B column chromatography. Three fractions, fractions I, II, and HI from Fig. 1 , were subjected to gel electrophoresis and transferred to nitrocellulose membrane as reported previously (23) . Immunostaining was performed using anti rat T-kininogen polyclonal antibody and horseradish peroxidase-conjugated goat antibody against rabbit IgG as reported previously (13) . I, fraction I; II, fraction II; III, fraction HI. min per absorbance unit) was prepared as described previously (12) . Endoglycosidase H was purchased from Seikagaku Kogyo, Tokyo. APMSF was a product of Wako Pure Chemical Industries, Osaka. Leupeptin was a product of Nihon Kayaku, Tokyo. Pepstatin A was purchased from Peptide Institute, Minoh, Osaka. Treatment of rats with lipopolysaccharide, immunoblotting of T-kininogens, pyroglutamyl aminopeptidase treatment, reduction and pyridylethylation of T-kininogens, and amino acid sequence analysis were performed as described previously (12) . SDS-PAGE and native PAGE were performed as reported by Laemmli (16) and by Davis (17) , respectively. Protein was stained with Coomassie Brilliant Blue R-250. Absorbance at 492 nm was measured using an EIA plate reader model 2550 (Bio-Rad).
Measurement of T-Kininogen by ELISA-Each

Purification of Microsomal T-Kininogens from Rat
Liver-Livers (wet weight 128 g) were isolated from 12 rats, 2 days after the injection of lipopolysaccharide, and perfused with a cold solution of 20 mM Tris-HCl, pH 7.6, containing 2 mM MgCl,, 50 mM KC1, 0.25 M sucrose, 1 mM EDTA, 0.1 mM APMSF, 0.1 mM leupeptin, and 0.02 mM pepstatin A. They were homogenized in 5 volumes of the above solution with a Potter homogenizer, and the homogenate was centrifuged for 10 min at 8,400 rpm. The supernatant was centrifuged for 90 min at 31,000 rpm. The pellet was suspended in the solution for perfusion of liver to make a final protein concentration of 5 mg per ml. Sodium deoxycholate (5% solution) was added to the suspension to make a final concentration of 0.05%. After being stirred for 30 min at 4"C, the suspension was centrifuged for 30 min at 35,000 rpm. The supernatant was applied to a column (4.6x20.5 cm) of DEAE-Sepharose CL-6B, which had been equilibrated with 20 mM Tris-HCl, pH 8.0, containing 3 mM benzamidine. After washing of the column with 1.5 liters of the equilibration buffer, proteins were eluted with a linear salt gradient formed from 2 liters each of the buffer and the buffer containing 0.3 M NaCl and fractions of 10 ml were collected. T-Kininogen as assayed by ELISA was separated into three peaks (Fig. 1) . Immunoblotting Vol. Ill, No. 5, 1992 patterns of the three fractions are shown in Fig. 2 . Fractions I and II both gave a single band with slower mobility than T-kininogen from plasma on native PAGE, while fraction HI showed the same mobility as that of T-kininogen from plasma. Fractions I and II were, separately, applied to a column (1.5x4.5 cm) of monoclonal antibody-conjugated Affigel 10, equilibrated with 20 mM Tris-HCl, pH8.0, containing 0.5 M NaCl. The column was washed with the equilibration buffer, and T-kininogen was eluted with 0.1 M glycine-HCl, pH 2.3. T-Kininogen from fraction I gave a single band on native PAGE, and was designated as microsomal TI-kininogen. On the other hand, T-kininogen from fraction II showed two bands on native PAGE and it was subjected to further purification. T-Kininogen from fraction II was dialyzed against 2 liters of 20 mM Tris-HCl, pH 8.0, overnight and applied to a column (0.75 X 7.5 cm) of DEAE-5PW equilibrated with 20 mM Tris-HCl, pH 8.0. Protein was eluted with a linear salt gradient to 0.2 M NaCl during 90 min with a flow rate of 1 ml/min, using an FPLC system (Pharmacia) (Fig. 3) . The T-kininogen eluted with 0.06 M NaCl corresponded to T-kininogen from fraction I, TI-kininogen, on native PAGE. Another kininogen was eluted with 0.08 M NaCl and gave a single band with faster mobility than T-kininogen from fraction I on native PAGE. The latter kininogen was designated as microsomal THkininogen. =O.O5). The mixture was incubated for 60 min at 37"C.
Treatment of T-Kininogens with Endoglycosidase H or
Quantitative Analysis of TI-and TU-Kininogens in Microsomes from Non-Inflamed and Inflamed Rats-The supernatant fractions of the sodium deoxycholate-treated microsomes from non-inflamed and inflamed rat liver prepared as described above were subjected to native PAGE on a 7.5% polyacrylamide gel. After electrotransfer from the gel onto a nitrocellulose membrane, the membrane was treated with anti T-kininogen rabbit antiserum as described previously (13) . After development with 4-chloronaphthol, the T-kininogen band was quantitated densitometrically using a TLC scanner, DR-2 (Shimadzu, Kyoto). The standard curve was made by the same procedures using purified microsomal T-kininogen.
RESULTS
Immunoblotting of T-Kininogens in Plasma of Rats after the Injection of Lipopolysaccharide-Lipopolysaccharide
was injected into five groups of three rats, one group being the control. Rats of the other groups were killed after the 1st, 2nd, 4th, and 15th days, respectively. Figure 4 shows immunoblotting patterns of T-kininogens in plasma of non-inflamed rats and inflamed rats. In non-inflamed rats, a single band corresponding to TI-kininogen was detected. At the 1st or 2nd day after injection, the band of TI-kininogen increased with increase of the band of TII-kininogen and thereafter both of them decreased. The pattern in plasma at the 15th day was almost the same as that of control plasma. This result indicates that TI-kininogen is mainly present in non-inflamed rat plasma and that plasma TI-and TH-kininogens both increase after the injection of lipopolysaccharide.
Purification of Microsomal T-Kininogens from Inflamed Rat Liver-T-Kininogens
from microsomal fraction of inflamed rat liver were purified by chromatographies on columns of DEAE-Sepharose CL-6B and DEAE-5PW and by affinity chromatography on a column of anti T-kininogen monoclonal antibody, as described in "MATERIALS AND METHODS". Microsomal T-kininogens gave single bands with different mobility on native PAGE, which migrated more slowly than plasma TI-and TH-kininogens (Fig. 5) . However, microsomal TI-and TE-kininogens showed the same mobility on SDS-PAGE. Their mobility on SDS-PAGE did not change after treatment with rat urinary kallikrein (Fig. 6) . Their mobility did change after treatment with endoglycosidase H, whereas that of T-kininogen from plasma did not change (Fig. 7) . Amino terminal amino acid sequences of two microsomal pyridylethylated Tkininogens after pyroglutamyl aminopeptidase treatment were identical with those of TI-and TQ-kininogens from rat plasma, as shown in Table I . These results indicate that microsomal TI-and TH-kininogens correspond to plasma TI-and TTI-kininogens, respectively. Yields of microsomal Groups of three rats were injected with lipopolysaccharide and plasma was collected at the 1st, 2nd, 4th, and 15th days as described under 'MATERIALS AND METHODS." T-Kininogen in plasma was detected by immunostaining as reported previously {13). Control: non-inflamed rat plasma. The left two columns show the mobility of purified TI-and Tll-kininogens from inflamed rat plasma, respectively.
(1) (2) (3) (4) T-kininogen were 0.5 mg for Tl-kininogen and 0.2 mg for TH-kininogen from 12 rat livers. Fraction EH from DEAESepharose CL-6B column chromatography was not sub- jected to purification, because it corresponded to mature T-kininogen on immunoblotting as shown in Fig. 2 .
Amounts of TI-and TU-Kininogens in Liver Microsomes of Non-Inflamed and Inflamed
Rats-To estimate the ratio of microsomal TI-and TTJ-kininogens, the supernatant of sodium deoxycholate-treated homogenate was prepared from liver of non-inflamed and inflamed rats, as described under "MATERIALS AND METHODS." As shown in Fig. 8 , microsomal TI-and TEI-kininogens were detected by immunoblotting of the homogenates of the liver from both non-inflamed and inflamed rats. Each band was quantitated from a standard curve which was made by using the purified microsomal T-kininogens, as described under 'MATERIALS AND METHODS." As shown in Table II , the ratio of the microsomal Tl-kininogen to Tll-kininogen was almost the same in non-inflamed and inflamed rats. These results indicate that TI-and Tll-kininogens are both synthesized in the liver of non-inflamed rat and that they increased by the injection of lipopolysaccharide. This finding seems inconsistent with previous reports that Tll-kininogen was not significantly detected in non-inflamed rat plasma (12, 13) .
DISCUSSION
Two different types of kininogens, K-kininogen and Tkininogen, which are derived from different genes, are present in rat plasma (6, 7) . T-Kininogen is present only in rat plasma and is induced by inflammatory response (3-5, Vol. Ill, No. 5, 1992 
8-11).
The function of T-kininogen as a precursor of T-kinin remains to be established since the in vivo significance of T-kinin releasing enzymes is not fully understood (18) (19) (20) (21) . The function of T-kininogen as a cysteine protease inhibitor may be significant in inflammation since its plasma concentration increases after the injection of lipopolysaccharide or turpentine (3) (4) (5) . T-Kininogen consists of two highly homologous proteins, TI-and TH-kininogens, in which 18 amino acid residues are substituted among 403 amino acid residues (7). Several investigators have demonstrated that mRNAs for TI-and Til-kininogens are almost equally present in rat liver and are increased by the injection of lipopolysaccharide or turpentine {14, 15). On the contrary, we have shown that only TI-kininogen is significantly present in non-inflamed rat plasma, but increases together with TH-kininogen after the injection of lipopolysaccharide {12, 13). In the present study, the microsomal TI-and TTI-kininogens were isolated from inflamed rat liver. They were indistinguishable from plasma TI-and Til-kininogens in terms of the amino acid composition and the amino terminal amino acid sequence. When the microsomal T-kininogens from non-inflamed rat liver were examined by immunoblotting, two kininogens with different mobility were observed, which corresponded to microsomal TI-and TEI-kininogens purified from inflamed rat liver. Therefore, the presence of both TI-and TEI-kininogens was proved in the microsomes of noninflamed rat liver. The quantitative experiments on the amounts of TI-and TEI-kininogens in the microsomes from inflamed and non-inflamed rat liver indicate that the ratio of TI-kininogen to TH-kininogen is not different between inflamed and non-inflamed rat liver. This result seems inconsistent with the present and previous finding that TH-kininogen is not significantly present in non-inflamed rat plasma {12, 13). We can speculate that TT-and TTI-kininogens are equally synthesized in microsomes of non-inflamed rat liver, but Tll-kininogen is not secreted into plasma. Another possibility is that TH-kininogen is more unstable than TI-kininogen in the circulation. Although the mechanism is still unknown, we will discuss how TI-and TQ-kininogens from microsomes and plasma are different in terms of protein moieties and carbohydrate moieties in the following section.
(1) Difference of Plasma T-Kininogens-As reported previously (13) , the sialic acid content of TEE-kininogen from inflamed rat plasma was larger than that of TI-kininogen from inflamed plasma. Since the potential carbohydrate-linked asparagine residues are conserved between TI-and Til-kininogens (6, 7), the difference in sialic acid content may be due to the difference of the numbers of carbohydrate-linked Ser/Thr residues. In fact, five substitutions of Ser/Thr to other amino acid residues are found in the amino acid sequences of TI-and TTJ-kininogens, as shown in Table HI . However, different mobility of plasma TI-and TEI-kininogens was still observed after treatment with sialidase (23) . This means that the difference of mobility of TI-and TEI-kininogens is due to not only different sialic acid content, but also different charge distribution of the protein moieties. Actually, TEE-kininogen contains one less basic amino acid residue and one more acidic residue than TI-kininogen (Table EH) .
(2) Difference of Microsomal T-Kininogens-The mobilities of microsomal TI-and TEE-kininogens were also different on native PAGE. Since their mobilities on SDS-PAGE changed after endoglycosidase H treatment, microsomal T-kininogens contain high mannose-type carbohydrate chains which do not include sialic acid (25, 26) . Therefore, this result suggests that the different mobility of microsomal TI-and TEI-kininogens on native PAGE is due to different charge distribution of the protein moieties as discussed for plasma T-kininogens. Hayashi et al. demonstrated that plasma of B/N Katholiek strain rat does not contain K-kininogen, but the liver does (22) . They have recently shown that K-kininogen is localized in the lysosome fraction of the rat liver (23) . Although K-kininogen in the rat has not been fully characterized, it can be speculated that it is not normally secreted but is transported to lysosomes as a consequence of the small difference of the carbohydrate chains and/or protein moiety. On the other hand, Cole and Schreiber (24) have reported that only TI-kininogen was found in plasma of Buffalo strain rat even after treatment with turpentine, although mRNAs for TEand TEE-kininogens were detected in the rat liver.
It has been established that secretion of a protein with incorrect folding is hindered by the interaction with resident proteins in the endoplasmic reticulum (27) . We can speculate that one of the T-kininogens or abnormal Kkininogen in rat is prevented from being secreted or transported to lysosomes after synthesis as a consequence of the small difference in carbohydrate chains and/or protein moiety. However, the possibility can not be completely ruled out that they are all normally secreted but are differently metabolized in the circulation.
